Comparison of Metyrapone, OSilodrostat and KEToconazolE in the short-term thERapy of endogenous Cushing's syndrome: preliminary results of the MOSKETEER study

Authors

Mario Detomas

Published

May 2, 2023

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Endocrine Abstracts

Topics

DOI

https://doi.org/10.1530/endoabs.90.p811

Comparison of Metyrapone, OSilodrostat and KEToconazolE in the short-term thERapy of endogenous Cushing's syndrome: preliminary results of the MOSKETEER study

Authors

Mario Detomas

Published

May 2, 2023

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Endocrine Abstracts

Topics

DOI

https://doi.org/10.1530/endoabs.90.p811

Paper

Paper

Paper

Paper

Comparison of Metyrapone, OSilodrostat and KEToconazolE in the short-term thERapy of endogenous Cushing's syndrome: preliminary results of the MOSKETEER study

Supporters

Journal

Topics

DOI

Comparison of Metyrapone, OSilodrostat and KEToconazolE in the short-term thERapy of endogenous Cushing's syndrome: preliminary results of the MOSKETEER study

Supporters

Journal

Topics

DOI